Save your place

Sign in to WhoBought

Please try again later.

Enanta Pharmaceuticals, Inc. (ENTA) institutional ownership

Latest close $13.16 Jul 20, 2026
Market cap$152M 52-week range SectorHealthcare
Funds holding · Q1 2026
122
reported ENTA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
68 buyers · 54 sellers

Enanta Pharmaceuticals, Inc. (ENTA) price and institutional activity

Dates

Q1 2026

$0 bought by 68 investors
Spruce Street Capital LPMillennium Management LLC +66 more
$0 sold by 54 investors
Point72 Asset Management, L.P.Marshall Wace, LLP +52 more
Bought Sold Totals per quarter; hover a bar for the names.

Enanta Pharmaceuticals, Inc. (ENTA) institutional activity · 122

Investor Type Est. change Change Δ Own Date
Spruce Street Capital LP · Added
Change +543K Date Q1 2026
Spruce Street Capital LP Added· Q1 2026 +543K Q1 2026
Point72 Asset Management, L.P. · Exited
Change −439K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −439K −100.0% Q1 2026
Millennium Management LLC · Added
Change +212K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +212K Q1 2026
Marshall Wace, LLP · Reduced
Change −175K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −175K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +169K +181.8% Q1 2026
Two Sigma Advisers, LP · Exited
Change −143K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −143K −100.0% Q1 2026
Stonepine Capital Management, LLC · Exited
Change −100K Δ Own −100.0% Date Q1 2026
Stonepine Capital Management, LLC Exited· Q1 2026 −100K −100.0% Q1 2026
Krensavage Asset Management, LLC · Added
Change +100K Date Q1 2026
Krensavage Asset Management, LLC Added· Q1 2026 +100K Q1 2026
Farallon Capital Management LLC · Added
Change +100K Δ Own +3.6% Date Q1 2026
Farallon Capital Management LLC Added· Q1 2026 +100K +3.6% Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −97K Δ Own −57.7% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −97K −57.7% Q1 2026
Qube Research & Technologies Ltd · Added
Change +85K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +85K Q1 2026
BNP Paribas Financial Markets · Reduced
Change −83K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −83K Q1 2026
Geode · Added
Change +79K Date Q1 2026
Geode Added· Q1 2026 +79K Q1 2026
AQR Capital Management LLC · Added
Change +78K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +78K Q1 2026
Schwab · Added
Change +76K Date Q1 2026
Schwab Added· Q1 2026 +76K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 122

Famous investor activity in Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals, Inc. (ENTA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Vance Terry · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Vance Terry Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Russell Lesley · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Russell Lesley Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Peterson Kristine · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Peterson Kristine Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Hata Yujiro S. · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Hata Yujiro S. Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Foletta Mark G. · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Foletta Mark G. Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Carter Bruce L. A. · Director Grant (A) 20K
Owned 20K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Carter Bruce L. A. Director Grant (A) 20K 20K Mar 11, 2026 Mar 13, 2026
Kowalsky Matthew Paul · Officer Tax withholding or exercise payment (F) -$27K
Price $14.25 Qty -2K Owned 4K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Kowalsky Matthew Paul Officer Tax withholding or exercise payment (F) $14.25 -2K -$27K 4K Feb 12, 2026 Feb 13, 2026
Kowalsky Matthew Paul · Officer 2 operations 5K
Owned 1K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Kowalsky Matthew Paul Officer 2 operations 5K 1K Feb 12, 2026 Feb 13, 2026
Luu Brendan · Officer Tax withholding or exercise payment (F) -$46K
Price $14.25 Qty -3K Owned 42K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Luu Brendan Officer Tax withholding or exercise payment (F) $14.25 -3K -$46K 42K Feb 12, 2026 Feb 13, 2026
Luu Brendan · Officer 2 operations 7K
Owned 45K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Luu Brendan Officer 2 operations 7K 45K Feb 12, 2026 Feb 13, 2026
Kieffer Tara Lynn · Officer Tax withholding or exercise payment (F) -$46K
Price $14.25 Qty -3K Owned 34K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Kieffer Tara Lynn Officer Tax withholding or exercise payment (F) $14.25 -3K -$46K 34K Feb 12, 2026 Feb 13, 2026
Kieffer Tara Lynn · Officer 2 operations 7K
Owned 32K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Kieffer Tara Lynn Officer 2 operations 7K 32K Feb 12, 2026 Feb 13, 2026
Rottinghaus Scott T. · Officer Tax withholding or exercise payment (F) -$49K
Price $14.25 Qty -3K Owned 25K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Rottinghaus Scott T. Officer Tax withholding or exercise payment (F) $14.25 -3K -$49K 25K Feb 12, 2026 Feb 13, 2026
Rottinghaus Scott T. · Officer 2 operations 7K
Owned 23K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Rottinghaus Scott T. Officer 2 operations 7K 23K Feb 12, 2026 Feb 13, 2026
Or Yat Sun · Officer Tax withholding or exercise payment (F) -$49K
Price $14.25 Qty -3K Owned 375K Trade date Feb 12, 2026 Filed date Feb 13, 2026
Or Yat Sun Officer Tax withholding or exercise payment (F) $14.25 -3K -$49K 375K Feb 12, 2026 Feb 13, 2026
15 of 42
15 of 42 Sign in to continue to older insider transactions.

Enanta Pharmaceuticals, Inc. (ENTA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 1.9M
% of shares outstanding 9.2% Filing date Jan 24, 2024
BlackRock Inc. 1.9M 9.2% Jan 24, 2024
Vanguard Group Inc 1.8M
% of shares outstanding 8.5% Filing date Feb 13, 2024
Vanguard Group Inc 1.8M 8.5% Feb 13, 2024
Luly Jay R. 1.4M
% of shares outstanding 6.5% Filing date Dec 17, 2021
Luly Jay R. 1.4M 6.5% Dec 17, 2021
Armistice Capital, LLC
% of shares outstanding 4.7% Filing date Nov 14, 2024
Armistice Capital, LLC 4.7% Nov 14, 2024
Millennium Management LLC 731K
% of shares outstanding 3.5% Filing date Oct 17, 2024
Millennium Management LLC 731K 3.5% Oct 17, 2024
Renaissance Technologies LLC 714K
% of shares outstanding 3.5% Filing date Feb 10, 2022
Renaissance Technologies LLC 714K 3.5% Feb 10, 2022
State Street Corp
% of shares outstanding 2.0% Filing date Jan 22, 2024
State Street Corp 2.0% Jan 22, 2024
Farallon Capital Partners, L.P. 379K
% of shares outstanding 1.8% Filing date Jan 26, 2024
Farallon Capital Partners, L.P. 379K 1.8% Jan 26, 2024
8 of 11

Enanta Pharmaceuticals, Inc. (ENTA) ownership FAQ

Who owns ENTA?

122 reporting institutions disclosed ENTA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.